$0.80
+0.07 (+9.08%)
Open$0.74
Previous Close$0.73
Day High$0.80
Day Low$0.73
52W High$1.57
52W Low$0.38
Volume—
Avg Volume175.0K
Market Cap39.13M
P/E Ratio—
EPS$-0.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,181.0% upside
Current
$0.80
$0.80
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.18M | 15.27M | 16.61M |
| Net Income | 3.38M | 4.70M | 4.66M |
| Profit Margin | 22.3% | 30.8% | 28.0% |
| EBITDA | 5.75M | 6.30M | 6.21M |
| Free Cash Flow | 2.69M | 4.04M | 4.00M |
| Rev Growth | +21.2% | -3.4% | +2.7% |
| Debt/Equity | 0.41 | 0.36 | 0.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |